Virios Therapeutics Announces Positive Data Demonstrati

ATLANTA, July 17, 2023 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on...

Related Keywords

Lucinda Bateman , R Michael Gendreau , Nasdaq , Facebook , Linkedin , Exchange Commission , Bateman Horne Center , Virios Therapeutics Inc , Drug Administration , Brookings Institute , Twitter , Post Acute Sequelae , Orthostatic Intolerance , Global Impression , Medical Director , Chief Medical Officer , Securities Litigation Reform Act , Virios Therapeutic , Annual Report , Virios Therapeutics , Nasdaq Viri , Siri , Ibro , Fibromyalgia , Clinical Trials , Longcovid , Fatigue ,